Patients arrive at your institution with a complete, verified, FHIR-compatible longitudinal record — every prior encounter, every lab, every imaging study, every medication, pre-reconciled and VERUM-verified. Readmission risk is visible on the first screen of the chart. Your clinicians stop chasing records and start practicing medicine.
The AEVRUS Rosetta Stone Pipeline ingests records from every source a new patient brings — prior hospitals, outpatient clinics, pharmacies, imaging centers, wearables. Normalized, de-duplicated, coded in FHIR, VERUM-verified. Clinicians see a complete chart before the history-and-physical begins. Average first-visit reconciliation time drops from 45 minutes to under 5.
Reduced readmission rates, medication reconciliation accuracy, prior-authorization turnaround, and quality-metric reporting are measurable within the first quarter. Each becomes leverage in MACRA, MIPS, and commercial value-based contracts.
Patients who consent contribute de-identified observations to the AEVRUS Clinical Data Lake. Your research teams query population-scale, VERUM-verified longitudinal data through the Research Marketplace — IRB-aware, federated-compatible, without the two-year data-use agreement cycle. A research-competitive advantage that compounds.
AEVRUS sits above your existing EHR, not in place of it. FHIR R4 bidirectional integration. SMART on FHIR-compatible. No rip-and-replace. Go-live measured in weeks, not the 18-month implementations your team has learned to fear.
HIPAA Security Rule safeguards across administrative, physical, and technical layers. Business Associate Agreements available to covered entities and their business associates. Encryption: AES-256-GCM at rest, TLS 1.3 in transit, CRYSTALS-Kyber (ML-KEM, FIPS 203) post-quantum key encapsulation. Audit logging on every read and write. SOC 2 Type II in progress. HITRUST CSF planned Year 3. Data residency: AWS us-east-2 under HIPAA-eligible BAA.
The AEVRUS Split Vault architecture separates patient identity from clinical data at the storage layer — an Identity Vault for encrypted PHI and a Clinical Data Lake for de-identified longitudinal observations. The two datasets are linked only by a session-volatile derivation that does not persist beyond an authenticated session. Your institution's patients retain ownership of their records; you gain access through explicit patient consent, logged to an immutable audit trail. AEVRUS does not resell identifiable patient data. De-identified research access is governed by a structural de-identification pipeline, not a legal-only assurance.
A breach of the Clinical Data Lake exposes rich medical data without identity. A breach of the Identity Vault exposes names without clinical data. Only a simultaneous breach of both plus capture of an active session's volatile linkage key results in identifiable PHI exposure. De-identification is structural — architecture-enforced, not promise-based.
AEVRUS deploys as a platform layer above your existing EHR. No rip-and-replace. No data migration away from Epic, Cerner, or Athena. Integration is FHIR R4 bidirectional, SMART-on-FHIR compatible, and designed to be stood up in weeks rather than the 12–18 month enterprise implementation cycles your team has learned to fear.
AEVRUS ingests patient longitudinal records through the Rosetta Stone Pipeline — a FHIR-native ingestion layer that normalizes across sources (prior EHRs, imaging DICOM, pharmacy, wearable telemetry), de-duplicates, and VERUM-verifies.
AEVRUS surfaces a pre-reconciled FHIR bundle into your existing EHR's encounter view, plus an AI decision-support panel grounded in population-scale verified data. Clinicians interact with AEVRUS through the UI they already use.
The Split Vault architecture lives entirely inside the AEVRUS BAA boundary. Your institution's patient data flows through an authenticated session only; identifiable PHI never leaves the Identity Vault without patient consent and institutional BAA authorization.
Request the FHIR integration specification →
Selected Academic Medical Centers and integrated delivery networks. Contact for pilot eligibility criteria.
A 30-minute walkthrough with the AEVRUS team. We share the architecture diagram, a redlined sample BAA exhibit, and the deployment plan that would apply to your environment.
For CMIO, CIO, CFO, CMO, Compliance, or General Counsel. We respond within two business days.
AEVRUS operates as a network, and institutions that participate in network validation and data contribution share in the economics of that network. This is an optional commercial program separate from the clinical integration. Clinical operations, EHR integration, and patient record workflows do not depend on it.
Institutions that host AEVRUS validation nodes on existing or dedicated infrastructure receive a share of network transaction fees proportional to validation work. A dedicated node deployment guide is provided to qualifying institutions.
When patients consent to contribute de-identified observations to the Clinical Data Lake, institutions where that data was generated receive a share of downstream research access revenue. The revenue share is structured through the institutional BAA and is subject to the patient consent framework.
Institutions that hold AEVRUM (AVR) tokens can stake them to secure the network and receive a share of network fees. Staking is optional, reversible, and not tied to clinical operations.
Participation in network economics is commercial and does not affect patient care, clinician workflow, or data governance obligations.